Details for 2018726224
Up to date per 01.04.2026
Actions
Details for 2018726224
Granted/Registered
European Patent
11.03.2020 A
05.04.2023 B1
02.05.2017
US
201762500108 P
12.04.2018
US
201862656423 P
A61K 31/5377 20060101AFI20210121BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
COOKE, Vesselinac/o Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US
Information about Fees